Johnson & Johnson JNJ Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $96.36B+7.9% | $94.19B+6.0% | $92.15B+5.1% | $90.63B+4.7% | $89.33B+4.3% | ||
| $31.01B+9.5% | $30.26B+10.1% | $29.42B+8.4% | $29.08B+8.6% | $28.32B+7.4% | ||
| $65.36B+7.1% | $63.94B+4.2% | $62.73B+3.6% | $61.55B+2.9% | $61.01B+2.9% | ||
| 67.8%-0.5pp | 67.9%-1.2pp | 68.1%-1.0pp | 67.9%-1.1pp | 68.3%-0.9pp | ||
| $24.6B+8.2% | $23.68B+3.5% | $23.38B+5.2% | $22.93B+3.5% | $22.72B+3.9% | ||
| $243M+179% | $228M-2.6% | $186M-25.0% | $164M-55.1% | $87M-83.4% | ||
| $25.43B+20.7% | $25.29B+21.5% | $23.44B+6.3% | $21.45B-4.9% | $21.08B-4.6% | ||
| 26.4%+2.8pp | 26.8%+3.4pp | 25.4%+0.3pp | 23.7%-2.4pp | 23.6%-2.2pp | ||
| $1.04B+29.2% | $971M+28.6% | $894M+16.3% | $842M+9.6% | $804M+12.4% | ||
| $953M-26.7% | $1.06B-20.7% | $1.1B-22.2% | $1.17B-22.1% | $1.3B-8.9% | ||
| $24.94B-6.3% | $32.58B+95.2% | $31.5B+78.7% | $27.35B+40.2% | $26.6B+32.6% | ||
| $4.05B-15.5% | $5.93B+126% | $6.38B+123% | $4.69B+50.0% | $4.79B+60.3% | ||
| $21.04B-3.5% | $26.8B+90.6% | $25.12B+71.1% | $22.66B-40.4% | $21.81B-43.3% | ||
| 21.8%-2.6pp | 28.5%+12.6pp | 27.3%+10.5pp | 25%-18.9pp | 24.4%-20.5pp | ||
| $8.64-3.9% | $11.04+90.7% | $10.36+71.2% | $9.35-38.3% | $8.99-40.8% | ||
| $8.73-3.6% | $11.13+90.6% | $10.43+71.0% | $9.41-38.5% | $9.06-40.9% | ||
| 9.7B+0.2% | 9.7B-0.1% | 9.7B-1.4% | 9.7B-2.6% | 9.7B-4.6% | ||
| 9.6B0.0% | 9.6B0.0% | 9.6B-1.3% | 9.6B-2.5% | 9.6B-4.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $77M-98.4% | $7.69B+258% | $7.69B+258% | $5.42B+252% | $4.87B+293% | ||
| $14.97B-11.5% | $14.67B-14.9% | $15.71B-4.3% | $16.99B+14.0% | $16.92B+11.5% | ||
| —— | —— | —— | —— | —— | ||
| $117M-44.5% | $81M-61.6% | $17M-93.3% | $17M-96.3% | $211M-20.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $96.36B+7.9% | $94.19B+6.0% | $92.15B+5.1% | $90.63B+4.7% | $89.33B+4.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $33.17B+16.9% | $32.79B+16.5% | $30.83B+5.1% | $28.9B-3.1% | $28.37B-3.8% | ||
| 34.4%+2.7pp | 34.8%+3.1pp | 33.5%0.0pp | 31.9%-2.5pp | 31.8%-2.7pp | ||
| $25.43B+20.7% | $25.29B+21.5% | $23.44B+6.3% | $21.45B-4.9% | $21.08B-4.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Johnson & Johnson's revenue?
- Johnson & Johnson (JNJ) generated $96.4B in revenue over the trailing twelve months, up 7.9% year over year.
- Is Johnson & Johnson profitable?
- Johnson & Johnson reported $21.0B in net income over the trailing twelve months, a 21.8% net margin.
- What are Johnson & Johnson's profit margins?
- Gross margin is 67.8% and operating margin is 26.4%, with a 21.8% net margin.
- What is Johnson & Johnson's earnings per share?
- Johnson & Johnson's diluted EPS over the trailing twelve months is $8.64.
- Where does Johnson & Johnson's income statement data come from?
- Every line is extracted from Johnson & Johnson's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
